Development of novel nanomedicine for metabolic syndrome
Project/Area Number |
24680053
|
Research Category |
Grant-in-Aid for Young Scientists (A)
|
Allocation Type | Partial Multi-year Fund |
Research Field |
Biomedical engineering/Biological material science
|
Research Institution | Osaka University |
Principal Investigator |
Yoshioka Yasuo 大阪大学, 微生物病研究所, 特任准教授(常勤) (00392308)
|
Project Period (FY) |
2012-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥26,780,000 (Direct Cost: ¥20,600,000、Indirect Cost: ¥6,180,000)
Fiscal Year 2015: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
Fiscal Year 2014: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
Fiscal Year 2013: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
Fiscal Year 2012: ¥7,280,000 (Direct Cost: ¥5,600,000、Indirect Cost: ¥1,680,000)
|
Keywords | ナノ粒子 / フラーレン / ナノメディシン / メタボリックシンドローム / 慢性炎症疾患 / 安全性 |
Outline of Final Research Achievements |
Fullerene C60 derivatives are the most promising nanomaterials because of its unique ability to scavenge large numbers of free radicals. Therefore fullerene C60 derivatives with antioxidant effects have been expected to apply to the medicine for inflammatory disease. Here I showed that Fullerene C60 derivatives might be useful preventive therapeutics for metabolic syndrome.
|
Report
(5 results)
Research Products
(17 results)
-
-
-
-
-
[Presentation] Fullerene C60 derivatives suppress the acquired immune responses.2014
Author(s)
Yoshioka Y., Udaka A., Hirai T., Aoshima H., Kokubo K., Oshima T., Ohe T., Mashino T., Tsunoda S., Higashisaka K., Tsutsumi Y.
Organizer
Immunology 2014
Place of Presentation
Pittsburgh (USA)
Year and Date
2014-05-02 – 2014-05-06
Related Report
-
-
-
-
-
-
-
-
-
-
-
-